Physician profile
Kevin L Stevenson
NPI 1821042946
$61,810.35
in general payments reported to CMS, 2019-2025
7 companies · $2,565 in 2025
The $2,565 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,821 · 2020: $1,304 · 2021: $854 · 2022: $15K · 2023: $6,118 · 2024: $31K · 2025: $2,565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $8,440 · Food and Beverage: $2,217 · Royalty Or License: $1,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,500.00 |
| Travel and Lodging | $8,440.13 |
| Food and Beverage | $2,217.03 |
| Royalty Or License | $1,413.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $52,341.33 | 2020-2025 | Must, Nextar Spine Platform, Myspine |
| Globus Medical, INC. | $7,057.78 | 2019-2025 | Rise-L . Rise-L A/L, Rise |
| Boston Scientific Corporation | $1,705.41 | 2021-2025 | General - Pain Management, Fixate, Wavewriter Alpha Prime 16 |
| Degen Medical, INC. | $560.42 | 2020 | |
| Flowonix Medical Incorporated | $74.02 | 2019-2020 | |
| Djo, LLC | $44.32 | 2020-2023 | Cmf |
| Team 1, LLC | $27.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Stevenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.